# US 2015/0105343 A1 · Nucleoside supplementation to promote cellular function, genetic stability and regenerative applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105343 A1
- Document ID: US20150105343A1
- Status: Published application
- Kind: A1
- Application number: 14/516,451
- Filed: 2014-10-16
- Published: 2015-04-16
- Earliest claimed: 2013-10-16
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: James A. Byrne; Caius Radu; Patrick Lee
- Web page: https://patentgrep.com/patent/US20150105343A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- A61K 31/7064: containing condensed or non-condensed pyrimidines
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/10: Anti-acne agents
- A61P 17/16: Emollients or protectives, e.g. against radiation
- C12N 2500/40: Nucleotides, nucleosides or bases
- C12N 2500/98: Xeno-free medium and culture conditions
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

In various embodiments, a cell culture medium, or a nucleoside cocktail transmission (NCT) medium for the culture of stem cells with improved genetic stability, cellular function and regeneration ability is provided. Illustrative culture media comprise a basal culture medium for stem cells, where the culture medium is supplemented with one or more nucleoside triphosphates (e.g., dNTPs and/or NPs) or one or more precursors thereof. Illustrative NCT media comprise a delivery vehicle (e g. skin creams or other vehicle) containing one or more nucleoside triphosphates (e.g., dNTPs and/or NPs) or one or more precursors thereof. The NCT medium provides, inter alia, direct delivery of nucleoside cocktails into human tissues (such as skin) for regenerative, cosmetic and/or therapeutic purposes.

## Claims

### Claim 1

A cell culture medium for the culture of stem cells with improved genetic stability, said culture medium comprising:
a basal culture medium for stem cells, where said culture medium is supplemented with one or more nucleoside triphosphates or one or more precursors thereof.

### Claim 2

A nucleoside cocktail transmission (NCT) medium for improving somatic or stem cell genetic stability said medium comprising:
a cosmetic or pharmaceutical delivery vehicle; and
one or more nucleoside triphosphates or precursors thereof.

### Claim 3 (depends on 1)

The cell culture medium of claim 1, wherein said one or more nucleoside triphosphates are independently selected from the group consisting of deoxyadenosine triphosphate (dATP), deoxyguanosine triphosphate (dGTP), deoxycytidine triphosphate (NCTP), deoxythymidine triphosphate (dTTP) deoxyuridine triphosphate, adenosine triphosphate (ATP), guanosine triphosphate (GTP), cytidine triphosphate (CTP), 5-methyluridine triphosphate (m5UTP), and uridine triphosphate (UTP).

### Claim 4 (depends on 2)

The nucleoside cocktail transmission medium of claim 2, wherein said one or more nucleoside triphosphates are independently selected from the group consisting of deoxyadenosine triphosphate (dATP), deoxyguanosine triphosphate (dGTP), deoxycytidine triphosphate (NCTP), deoxythymidine triphosphate (dTTP) deoxyuridine triphosphate, adenosine triphosphate (ATP), guanosine triphosphate (GTP), cytidine triphosphate (CTP), 5-methyluridine triphosphate (m5UTP), and uridine triphosphate (UTP).

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The cell culture medium claim 1, wherein said culture medium is supplemented with one or more precursors of nucleoside triphosphates independently selected from the group consisting of deoxyadenosine triphosphate (dATP) precursor, deoxyguanosine triphosphate (dGTP) precursor, deoxycytidine triphosphate (NCTP) precursor, deoxythymidine triphosphate (dTTP) precursor, deoxyuridine triphosphate (dUTP) precursor, adenosine triphosphate (ATP) precursor, guanosine triphosphate (GTP) precursor, cytidine triphosphate (CTP) precursor, 5-methyluridine triphosphate (m5UTP) precursor, and uridine triphosphate (UTP) precursor.

### Claim 7 (depends on 2)

The NCT medium of claim 2, wherein said NCT medium comprises one or more precursors of nucleoside triphosphates independently selected from the group consisting of deoxyadenosine triphosphate (dATP) precursor, deoxyguanosine triphosphate (dGTP) precursor, deoxycytidine triphosphate (NCTP) precursor, deoxythymidine triphosphate (dTTP) deoxyuridine triphosphate (dUTP) precursor, adenosine triphosphate (ATP) precursor, guanosine triphosphate (GTP) precursor, cytidine triphosphate (CTP) precursor, 5-methyluridine triphosphate (m5UTP) precursor, and uridine triphosphate (UTP) precursor.

### Claim 8 (depends on 6)

The cell culture medium of claim 6, wherein said one or more precursors of nucleoside triphosphates comprise a nucleoside diphosphate or a nucleoside monophosphate.

### Claim 9 (depends on 7)

The NCT medium of claim 7, wherein said one or more precursors of nucleoside triphosphates comprise a nucleoside diphosphate or a nucleoside monophosphate.

### Claim at position 10

10-48. (canceled)

### Claim 49 (depends on 2)

The nucleoside cocktail transmission (NCT) medium of claim 2, wherein said NCT medium comprises a vehicle formulated for administration via a route selected from the group consisting of subcutaneous administration, parenteral administration, topical administration, oral administration, nasal or inhalation administration, local administration such as by paint, aerosol, or transdermally.

### Claim 50

(canceled)

### Claim 51 (depends on 49)

The nucleoside cocktail transmission (NCT) medium of claim 49, wherein said medium is formulated in a vehicle selected from the group consisting of a mud, an herbal mixture, a fat, an emulsions, a lotion, a cream, a gel, a biological, a solution, a spray, an ointment, a foams, a mousses, a liquid, a suspensions, a dispersion, an aerosol, a soap, a shampoo, and a conditioner.

### Claim 52 (depends on 2)

The NCT medium of claim 2, wherein said nucleoside triphosphate or precursor thereof is present at a concentration sufficient to improve the short term and/or long term genetic stability of stem cells as compared to the same cells in the same medium without supplementation by a nucleoside triphosphate or precursor thereof.

### Claim 53

(canceled)

### Claim 54 (depends on 1)

The cell culture medium of claim 1, wherein said nucleoside triphosphate or precursor thereof supplementing said culture medium, is present at a concentration sufficient to improve the short term and/or long term genetic stability of stem cells as compared to the same cells cultured in the same medium without supplementation by a nucleoside triphosphate or precursor thereof.

### Claim at position 17

55-60. (canceled)

### Claim 61 (depends on 1)

The cell culture medium of claim 1, wherein said cell culture medium is xenopathogen-free.

### Claim 62 (depends on 1)

The cell culture medium of claim 1, wherein said cell culture medium, is without animal or human derived serum albumin.

### Claim 63 (depends on 1)

The cell culture medium of claim 1, wherein the supplemented medium is selected from the group consisting of DMEM (Dulbecco's Modified Eagle's Medium), MEM (Minimal Essential Medium), BME (Basal Medium Eagle), RPMI 1640, DMEM/F-12 (Dulbecco's Modified Eagle's Medium: Nutrient Mixture F-12), DMEM/F-10 (Dulbecco's Modified Eagle's Medium: Nutrient Mixture F-10), α-MEM (α-Minimal essential Medium), G-MEM (Glasgow's Minimal Essential Medium), IMDM (Isocove's Modified Dulbecco's Medium), essential 8 (E8) medium, and KnockOut DMEM.

### Claim at position 21

64-65. (canceled)

### Claim 66

A somatic or stem cell culture or nucleoside cocktail transmission (NCT) culture, comprising:
cells in a basal culture medium for stem cells, where said culture medium is supplemented with one or more nucleoside triphosphates or one or more precursors thereof and/or
cells in a medium comprising a cosmetic or pharmaceutical delivery vehicle; and one or more nucleoside triphosphates or precursors thereof.

### Claim 67 (depends on 66)

The cell culture or NCT culture of claim 66, wherein said cells are cells selected from the group consisting of somatic cells or stem cells.

### Claim at position 24

68-75. (canceled)

### Claim 76

A method of reducing genetic instability of stem cells said method comprising culturing said cells in a cell culture medium comprising a basal culture medium for stem cells, supplemented with one or more nucleoside triphosphates or one or more precursors thereof.

### Claim 77

A method of performing autologous stem cell transfer, said method comprising isolating stem cells from a subject or generating IPSCs from said subject and expanding and/or culturing said stem cells or IPSCs in a cell culture medium comprising a basal culture medium for stem cells, supplemented with one or more nucleoside triphosphates or one or more precursors thereof.

### Claim 78

A method of promoting regeneration and/or maintenance of tissues, said method comprising administering to a subject, an NCT medium comprising a cosmetic or pharmaceutical delivery vehicle and one or more nucleoside triphosphates or precursors thereof.

### Claim at position 28

79-87. (canceled)
